AURA — AURA BIOSCIENCES Cashflow Statement
0.000.00%
Last trade - 00:00- $415.86m
- $271.62m
Annual cashflow statement for AURA BIOSCIENCES, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -35.3 | -58.8 | -76.4 | -86.9 | -106 |
| Depreciation | |||||
| Non-Cash Items | 2.33 | 6.09 | 6.83 | 8.53 | 14.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.315 | -3.1 | 4.44 | -2.64 | 5.97 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -32.4 | -54.6 | -63.8 | -79.8 | -84.7 |
| Capital Expenditures | -2.13 | -1.09 | -0.709 | -1.25 | -0.447 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -66.8 | -113 | 70.1 | 36 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.13 | -67.9 | -114 | 68.8 | 35.6 |
| Financing Cash Flow Items | -0.015 | 0 | 0.128 | 0.177 | 0.164 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 166 | 95.6 | 97.3 | 1.59 | 77.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 132 | -26.8 | -80.5 | -9.39 | 27.8 |